ADVERTISEMENT
How Race Affects the Treatment and Diagnostic Journey in IBD
In this video, sponsored by Takeda Pharmaceuticals, Angela Ward, DNP, FNP, from The Emory Clinic for Digestive Diseases, Atlanta, Georgia; Marie L. Borum, MD, EdD, professor of medicine and director of the Division of Gastroenterology and Liver Disease at The George Washington University, Washington, DC; and Ana Ingram, patient living with Crohn disease, discuss the ways in which the race of patients with inflammatory bowel disease can affect their diagnosis and care. ©2022 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. US-NON-8489v1.0 12/22
Disclaimer: The views and opinions expressed are those of the author(s) and do not necessarily reflect the official policy or position of Gastroenterology Learning Network or HMP Global, their employees, and affiliates. Any content provided by our bloggers or authors are of their opinion and are not intended to malign any religion, ethnic group, club, association, organization, company, individual, anyone, or anything.
